We are live on ! Find out more
DFTX

Definium Therapeutics
DFTX

172 hedge funds and large institutions have $289M invested in Definium Therapeutics in 2024 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 60 increasing their positions, 32 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

196% more call options, than puts

Call options by funds: $14.5M | Put options by funds: $4.88M

88% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 32

85% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 20

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

10% more funds holding

Funds holding: 157 → 172 (+15)

3% more capital invested

Capital invested by funds: $282M → $289M (+$7.25M)

4.22% less ownership

Funds ownership: 60.82% → 56.6% (-4.2%)

Holders
172
Holders Change
+15
Holders Change %
+9.55%
% of All Funds
2.27%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
37
Increased
60
Reduced
32
Closed
20
Calls
$14.5M
Puts
$4.88M
Net Calls
+$9.59M
Net Calls Change
+$7.49M

Top Buyers

1
BlackRock
BlackRock
New York
+$2.79M
2
AIC
AWM Investment Company
New York
+$2.34M
3
Marshall Wace
Marshall Wace
United Kingdom
+$1.47M
4
TCM
Tang Capital Management
California
+$1.38M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.37M

Top Sellers

1
DTC
Deep Track Capital
Connecticut
-$29.2M
2
CC
Commodore Capital
New York
-$25.4M
3
TLP
Tri Locum Partners
New York
-$5.79M
4
DCM
Driehaus Capital Management
Illinois
-$3.56M
5
ABG
Ally Bridge Group
New York
-$3.15M
Name Holding Trade Value Shares
Change 		Change in
Stake
Rafferty Asset Management
176
Rafferty Asset Management
New York
– -$106K -18,658 Closed
SPA
177
Sherbrooke Park Advisers
New York
– -$78.7K -13,827 Closed
CW
178
CreativeOne Wealth
Kansas
– -$70.9K -12,462 Closed
Voloridge Investment Management
179
Voloridge Investment Management
Florida
– -$63.7K -11,198 Closed
WA
180
Wealth Alliance
New York
– -$62.6K -11,000 Closed
William Blair & Company
181
William Blair & Company
Illinois
– -$62.6K -11,000 Closed
JIP
182
Jaffetilchin Investment Partners
Florida
– -$13.6K -2,389 Closed
NS
183
NBC Securities
Alabama
– -$3K -600 Closed
AFG
184
Albion Financial Group
Utah
– -$752 -132 Closed
TVWM
185
Tower View Wealth Management
Wisconsin
– -$569 -100 Closed
CPA
186
Capital Performance Advisors
California
– -$455 -80 Closed
AF
187
Arrow Financial
New York
– -$376 -66 Closed
WIM
188
Westside Investment Management
California
– -$376 -66 Closed
TWD
189
True Wealth Design
Ohio
– -$109 -19 Closed
SIC
190
SJS Investment Consulting
Ohio
– -$69 -12 Closed
M
191
MOTCO
Texas
– -$57 -10 Closed
4 5 6 7
8

DFTX Hedge Fund Activity: Q4 2024 in Review

172 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Definium Therapeutics (DFTX) for Q4 2024, worth a combined $289M — up 2.6% from $282M a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new DFTX positions and 20 closed out — a net gain of 17 holders — while 60 added to existing stakes and 32 trimmed.

The largest buyer was BlackRock, adding an estimated $2.79M. The largest seller was Deep Track Capital, cutting an estimated $29.2M.

  • 172 institutional investors held Definium Therapeutics (DFTX) as of Q4 2024, up from 157 in Q3 2024.
  • Funds reported $289M of Definium Therapeutics stock for Q4 2024, up 2.6% quarter-over-quarter.
  • 37 funds opened new Definium Therapeutics positions in Q4 2024 and 20 closed out, a net change of +17 holders.
  • The largest Definium Therapeutics buyer in Q4 2024 was BlackRock, an estimated $2.79M added.
  • The largest Definium Therapeutics seller in Q4 2024 was Deep Track Capital, an estimated $29.2M sold.

Based on aggregated 13F filings for Q4 2024.